SCHEMBL4846536

SCHEMBL4846536

Cc1ccc(OCCN(C)C)c(C=O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C19 P33261 1/20 0.53
KDM4E B2RXH2 6/20 0.52
GAA P10253 3/20 0.52
ALDH1A1 P00352 5/20 0.51
TDP1 Q9NUW8 2/20 0.51
ADRB2 P07550 1/20 0.50
ADRB1 P08588 1/20 0.50
HTR7 P34969 3/20 0.42
DRD2 P14416 1/20 0.42
DRD1 P21728 1/20 0.42
DRD4 P21917 1/20 0.42
DRD5 P21918 1/20 0.42
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
GPR55 Q9Y2T6 1/20 0.41
ACHE P22303 1/20 0.41
MAPK1 P28482 1/20 0.41
HRH1 P35367 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849767 0.88 KDM4E (0.47) CYP1A2CYP2D6CYP2C19KDM4EGAA
SCHEMBL4849200 0.84 KDM4E (0.47) CYP1A2CYP2D6CYP2C19KDM4EGAA
SCHEMBL4849949 0.84 ADRB2 (0.45) CYP1A2CYP2D6CYP2C19KDM4EGAA
SCHEMBL29189171 0.83 KDM4E (0.56) CYP1A2CYP2C19KDM4EGAAALDH1A1
SCHEMBL29189194 0.83 ALDH1A1 (0.49) KDM4EALDH1A1ADRB2ADRB1HTR7
SCHEMBL4856463 0.83 PTGDR2 (0.57) CYP1A2CYP2D6CYP2C19KDM4EGAA
SCHEMBL30304134 0.83 KDM4E (0.56) CYP1A2CYP2C19KDM4EGAAALDH1A1
SCHEMBL30304109 0.83 ALDH1A1 (0.49) KDM4EALDH1A1ADRB2ADRB1HTR7
SCHEMBL4854088 0.82 KDM4E (0.45) CYP1A2CYP2D6CYP2C19KDM4EGAA
SCHEMBL14448836 0.81 KDM4E (0.51) KDM4EALDH1A1ADRB2ADRB1HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed